Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tilray Brands, Inc. - Common Stock (NQ:TLRY)

1.490 +0.010 (+0.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tilray Brands, Inc. - Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
99 100 Next >
Redecan Cannabis Launches New Limited-Edition Genetics and Expands Signature 'Wrapped & Redee' Pre-roll Line for the Holidays
From Tilray Brands, Inc.
Via GlobeNewswire
How Is The Market Feeling About Tilray Brands?
 
Via Benzinga
420 with CNW — Portugal Looks Forward to Standing Out as a Medical Marijuana Hub
Via CannabisNewsWire
Topics Cannabis
420 with CNW — UN Human Rights Commissioner Condemns War on Drugs as a Total Failure
Via CannabisNewsWire
Topics Cannabis
Is Tilray Brands Stock a Buy?
Via The Motley Fool
Tilray Introduces New Indica Strain With 'Potent THC And A Unique Terpene Profile'
 
Via Benzinga
1 Stock to Avoid After the Election Results
Via The Motley Fool
Unwrap the Ultimate Holiday Experience with Good Supply’s Flavour-Packed Innovations
Experience the Pinnacle of Hard-Hitting Elevation with Good Supply’s Latest Product Release, Featuring JUICED XTREME, 2g Vapes, and Festive Monsters Pre-Roll: The Grump 
From Tilray Brands, Inc.
Via GlobeNewswire
Tilray Alternative Beverages Unveils HERB & BLOOM: A Cutting-Edge Era of Hemp-Derived Delta-9 THC Beverages
From Tilray Brands, Inc.
Via GlobeNewswire
Tilray Canada Launches THC Beverage Holiday Campaign Featuring XMG and Mollo Brands for Festive Season Celebrations
From Tilray Brands, Inc.
Via GlobeNewswire
How Is The Market Feeling About Tilray Brands?
 
Via Benzinga
EXCLUSIVE: Drug Expert Dr. Carl Hart Slams Cannabis Prohibition Amid Hemp-THC Surge
Dr. Carl Hart discusses hemp THC, unregulated markets, and the need for federal cannabis legalization to reduce risks and protect consumers. 
Via Benzinga
Topics Cannabis
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK. 
Via Benzinga
Topics Cannabis
Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow
Decibel, a leading Canadian pre-roll franchise, may trade closer to larger market-cap cannabis stocks, according to analyst Pablo Zuanic. 
Via Benzinga
Topics Cannabis
If You'd Invested $1,000 in Tilray Stock 6 Years Ago, Here's How Much You'd Have Today
Via The Motley Fool
Hop Valley Brewing Co. and Portland Trail Blazers Partner to Launch New Hop Box Bar at Moda Center
From Tilray Brands, Inc.
Via GlobeNewswire
Down 40% This Year, Is Tilray Brands Stock Due for a Much Better Performance in 2025?
Via The Motley Fool
Three Reasons to Avoid TLRY and One Stock to Buy Instead
What a brutal six months it’s been for Tilray. The stock has dropped 22% and now trades at $1.42, rattling many shareholders. This was partly driven by its softer quarterly results and may have... 
Via StockStory
Topics Cannabis
The Broken Coast Difference: Tilray Brands’ Broken Coast Craft Cannabis Introduces New Premium Strain ‘Platinum Pavé’
From Tilray Brands, Inc.
Via GlobeNewswire
Meta Faces Multibillion-Dollar Lawsuit As Supreme Court Dismisses Appeal In Cambridge Analytica Data Scandal
Meta Platforms faces a multibillion-dollar lawsuit after the U.S. Supreme Court dismissed its appeal over the Cambridge Analytica data scandal, potentially leading to a $2 billion settlement. 
Via Benzinga
Topics Lawsuit
420 with CNW — New Study Explores the Health Conditions for Which Individuals Use Medical Cannabis
Via CannabisNewsWire
Topics Cannabis
German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
Medical cannabis users still represent less than 0.3% of the population, indicating significant potential for market expansion. 
Via Benzinga
Topics Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56. 
Via Benzinga
Topics Cannabis ETFs Government
Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameday Gold Lager, a New Craft Beer in Support of University of Washington Athletes
From Tilray Brands, Inc.
Via GlobeNewswire
Tilray Brands Unveils 2024 Holiday Cannabis Gift Guide
Indulge in Premium Chocolate Edibles, Cannabis-Infused Drinks, New Pre-Rolls, and Top-Quality Flower - the Perfect Selection for Cannabis Connoisseurs this Festive Season! 
From Tilray Brands, Inc.
Via GlobeNewswire
Tilray Brands Gets Festive with its 2024 Holiday Beverage Gift Guide
From Tilray Brands, Inc.
Via GlobeNewswire
Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years
Via The Motley Fool
Topics Cannabis
These 2 Marijuana Stocks Could Surge Under Trump's Second Term
Via The Motley Fool
Topics Cannabis Government
Beverages, Alcohol and Tobacco Stocks Q3 Recap: Benchmarking Tilray Brands (NASDAQ:TLRY)
Looking back on beverages, alcohol and tobacco stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Tilray Brands (NASDAQ:TLRY) and its peers. 
Via StockStory
Topics Cannabis
Q3 Earnings Outperformers: Celsius (NASDAQ:CELH) And The Rest Of The Beverages, Alcohol and Tobacco Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Celsius (NASDAQ:CELH) and the best and worst... 
Via StockStory
Topics Cannabis
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.